About Novocuff
Novocuff is a company based in San Luis Obispo (United States) founded in 2021 by Amelia Degenkolb and Donald Lee. Novocuff has raised $28 million across 3 funding rounds from investors including March of Dimes, Laborie Medical and HHS. Novocuff offers products and services including Novocuff Cervical Control System. Novocuff operates in a competitive market with competitors including Materna Medical, NUA Surgical, CooperSurgical, Alydia Health and Clinical Innovations, among others.
- Headquarter San Luis Obispo, United States
- Founders Amelia Degenkolb, Donald Lee
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Novocuff, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$28 M (USD)
in 3 rounds
-
Latest Funding Round
$26 M (USD), Series A
Jun 04, 2024
-
Investors
March of Dimes
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Novocuff
Novocuff offers a comprehensive portfolio of products and services, including Novocuff Cervical Control System.
Supports cervix to retain amniotic fluid and prevent preterm birth in at-risk pregnancies.
People of Novocuff
Unlock access to complete
Unlock access to complete
Funding Insights of Novocuff
Novocuff has successfully raised a total of $28M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $26 million completed in June 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Novocuff
Novocuff has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include March of Dimes, Laborie Medical and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in disruptive health technologies for life-saving impact.
|
Locked | Locked | Locked | |
|
Diversified alternative assets are managed through investment strategies.
|
Locked | Locked | Locked | |
|
Avestria Ventures is focused on funding women's health and life science ventures.
|
Locked | Locked | Locked |
Investor details for Novocuff
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Novocuff
Investment portfolio details for Novocuff
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Novocuff
Detailed financials for Novocuff
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novocuff Comparisons
Peer comparison for Novocuff
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Novocuff
Novocuff operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Materna Medical, NUA Surgical, CooperSurgical, Alydia Health and Clinical Innovations, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of medical devices for women's pelvic health
|
|
| Locked | Locked | Locked |
Specialized surgical retractors are developed to improve C-Section safety.
|
|
| Locked | Locked | Locked |
Offers medical devices for fertility, contraception, and women's health care globally.
|
|
| Locked | Locked | Locked |
Medical devices for postpartum hemorrhage treatment are developed.
|
|
| Locked | Locked | Locked |
Medical devices for mothers and their babies
|
Detailed competitors of Novocuff
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novocuff
Complete news archive for Novocuff
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novocuff
Novocuff was founded in 2021.
Novocuff is headquartered in San Luis Obispo, United States. It is registered at San Luis Obispo, California, United States.
Amelia Degenkolb is the current CEO of Novocuff. They have also founded this company.
Novocuff is a funded company, having raised a total of $28M across 3 funding rounds to date.
Developer of medical device to prevent infant mortality caused by preterm birth complications. It offers Novocuff Cervical Control System (CCS) that stabilizes and closes the cervix to retain amniotic fluid and sustain cervical length to extend pregnancy.
Novocuff's top competitors include Materna Medical, Alydia Health and NUA Surgical.
Novocuff offers Novocuff Cervical Control System.
Novocuff has 7 investors. Key investors include March of Dimes, Laborie Medical, HHS, AXA Investment Managers, and Laerdal Million Lives Fund.